Sanofi estimates a currency impact on third-quarter business earnings per share of 8.5%-9.5% and expects sales to reduce by up to 8.5%.
Sanofi estimates a currency impact on third-quarter business earnings per share of 8.5%-9.5% and expects sales to reduce by up to 8.5%.